Antiretroviral treatment-induced decrease in immune activation contributes to reduced susceptibility to tuberculosis in HIV-1-TB co-infected persons
View ORCID ProfileKatalin A. Wilkinson, Deborah Schneider-Luftman, Rachel Lai, Christopher Barrington, Nishtha Jhilmeet, David M Lowe, Gavin Kelly, Robert J Wilkinson
doi: https://doi.org/10.1101/2020.11.13.20231274
Katalin A. Wilkinson
1The Francis Crick Institute, London, NW1 1AT, UK
2Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Observatory 7925, South Africa
Deborah Schneider-Luftman
1The Francis Crick Institute, London, NW1 1AT, UK
Rachel Lai
3Department of Infectious Disease, Imperial College London, W12 0NN, UK
Christopher Barrington
1The Francis Crick Institute, London, NW1 1AT, UK
Nishtha Jhilmeet
2Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Observatory 7925, South Africa
David M Lowe
2Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Observatory 7925, South Africa
4Institute of Immunity and Transplantation, University College London, NW3 2QG, UK
Gavin Kelly
1The Francis Crick Institute, London, NW1 1AT, UK
Robert J Wilkinson
1The Francis Crick Institute, London, NW1 1AT, UK
2Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Observatory 7925, South Africa
3Department of Infectious Disease, Imperial College London, W12 0NN, UK
Data Availability
all data that is not in the supplements is available on request and RNAseq data was deposited to Gene Expression Omnibus (GEO) under accession number GSE158208.
Posted November 16, 2020.
Antiretroviral treatment-induced decrease in immune activation contributes to reduced susceptibility to tuberculosis in HIV-1-TB co-infected persons
Katalin A. Wilkinson, Deborah Schneider-Luftman, Rachel Lai, Christopher Barrington, Nishtha Jhilmeet, David M Lowe, Gavin Kelly, Robert J Wilkinson
medRxiv 2020.11.13.20231274; doi: https://doi.org/10.1101/2020.11.13.20231274
Antiretroviral treatment-induced decrease in immune activation contributes to reduced susceptibility to tuberculosis in HIV-1-TB co-infected persons
Katalin A. Wilkinson, Deborah Schneider-Luftman, Rachel Lai, Christopher Barrington, Nishtha Jhilmeet, David M Lowe, Gavin Kelly, Robert J Wilkinson
medRxiv 2020.11.13.20231274; doi: https://doi.org/10.1101/2020.11.13.20231274
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2986)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12847)
- Forensic Medicine (12)
- Gastroenterology (839)
- Genetic and Genomic Medicine (4652)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2960)
- Health Policy (1076)
- Hematology (394)
- HIV/AIDS (938)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4441)
- Nursing (239)
- Nutrition (653)
- Oncology (2310)
- Ophthalmology (655)
- Orthopedics (260)
- Otolaryngology (328)
- Pain Medicine (285)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1205)
- Primary Care Research (506)
- Public and Global Health (7039)
- Radiology and Imaging (1557)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (387)
- Surgery (494)
- Toxicology (60)
- Transplantation (213)
- Urology (186)